首页> 外文期刊>Journal of immunology research. >CpG Oligodeoxynucleotides Enhance the Efficacy of Adoptive Cell Transfer Using Tumor Infiltrating Lymphocytes by Modifying the Th1 Polarization and Local Infiltration of Th17 Cells
【24h】

CpG Oligodeoxynucleotides Enhance the Efficacy of Adoptive Cell Transfer Using Tumor Infiltrating Lymphocytes by Modifying the Th1 Polarization and Local Infiltration of Th17 Cells

机译:CpG寡脱氧核苷酸通过修饰Th1极化和Th17细胞的局部浸润增强使用肿瘤浸润淋巴细胞的过继细胞转移的功效。

获取原文
           

摘要

Adoptive cell transfer immunotherapy using tumor infiltrating lymphocytes (TILs) was an important therapeutic strategy against tumors. But the efficacy remains limited and development of new strategies is urgent. Recent evidence suggested that CpG-ODNs might be a potent candidate for tumor immunotherapy. Here we firstly reported that CpG-ODNs could significantly enhance the antitumor efficacy of adoptively transferred TILs in vivo accompanied by enhanced activity capacity and proliferation of T cells and T cells, as well as a Th1 polarization immune response. Most importantly, we found that CpG-ODNs could significantly elevate the infiltration of Th17 cells in tumor mass, which contributed to anti-tumor efficacy of TILs in vivo. Our findings suggested that CpG ODNs could enhance the anti-tumor efficacy of adoptively transferred TILs through modifying Th1 polarization and local infiltration of Th17 cells, which might provide a clue for developing a new strategy for ACT based on TILs.
机译:使用肿瘤浸润淋巴细胞(TILs)的过继细胞转移免疫疗法是针对肿瘤的重要治疗策略。但是功效仍然有限,迫切需要开发新的策略。最近的证据表明,CpG-ODNs可能是肿瘤免疫疗法的有效候选者。在这里,我们首先报道了CpG-ODNs可以显着增强体内过继转移TILs的抗肿瘤功效,并伴随着增强的T细胞和T细胞活性和增殖以及Th1极化免疫反应。最重要的是,我们发现CpG-ODNs可以显着提高肿瘤组织中Th17细胞的浸润,这有助于TILs在体内的抗肿瘤功效。我们的发现表明,CpG ODN可以通过修饰Th1极化和Th17细胞的局部浸润来增强过继转移TIL的抗肿瘤功效,这可能为开发基于TIL的ACT新策略提供了线索。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号